Publication | Open Access

Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors

Bone DiseaseAdvanced CancerBone HealthMedicineCancer ManagementSkeletal-related EventsRandomized Phase 3Breast CancerOsteoporosisCancer TreatmentOncologyRadiation OncologyOrthopaedic SurgeryCancer Research